Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in Japan
-- Supplemental cohort of 12 Japanese patients to be added to global Phase 3 hypothalamic obesity trial, with dosing expected...
Month: February 2024
Quince Therapeutics Launches Scientific Advisory Board
World-renowned scientists and clinicians to provide expert insight and advice to support advancement of the company’s lead Phase 3 asset,...
Pool Corporation Reports Year End and Fourth Quarter 2023 Results; Provides 2024 Earnings Guidance
Highlights include:COVINGTON, La., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq/GSM:POOL) today announced full year and fourth quarter 2023...
ProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conference
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Feb. 22, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused...
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023
BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH),...
CLOUD DX Signs $230,000 Contract with US Internal Medicine Clinic
The Company has reported new contracts, renewals or orders valued at approximately $2.8 million CAD so far in 2024, outpacing...
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
Full year 2023 net revenues of $509 million and fourth quarter net revenues of $134 million PMA application for TTFields...
NeuroMetrix Reports Q4 and Full Year 2023 Business Highlights
WOBURN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the...
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
BURLINGTON, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development...
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis (UC)--Enrollment on target in EMERALD-2 phase 2b...
MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
Contacts For Media: media@mindmed.co For Investors: ir@mindmed.co Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (Cboe Canada: MMED) (the “Company” or “MindMed”),...
908 Devices to Participate in Upcoming Investor Conferences
Contacts Media Barbara Russo brusso@908devices.com Investor Carrie Mendivil IR@908devices.com 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and...
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed...
Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
KT-474/SAR444656 (IRAK4) Phase 2 program advancing in HS and AD with data expected in first half of 2025KT-621 (STAT6) expected...
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
-- Conference Call Scheduled for Thursday, February 29, 2024, at 8:00 a.m. ET -- NEWTON, Mass., Feb. 22, 2024 /PRNewswire/...
Kaltura Announces Financial Results for Fourth Quarter and Full Year 2023
NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kaltura, Inc. (“Kaltura” or the “Company”), the video experience cloud, today announced...
The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results
SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care...
H&E Equipment Services, Inc. Reports Fourth Quarter and Full Year 2023 Results
Contacts Leslie S. Magee Chief Financial Officer 225-298-5261 lmagee@he-equipment.com Jeffrey L. Chastain Vice President of Investor Relations 225-952-2308 jchastain@he-equipment.com H&E...
EnviroGold Global Appoints Mr. Kyle Appleby as CFO
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) (“EnviroGold Global”...
Cosmin Pitigoi to Join Flywire as Chief Financial Officer
BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (Flywire), a global payments enablement and software company, today...
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
REHOVOT, Israel, Feb. 22, 2024 /PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products,...
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
DURHAM, N.C., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully...
C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
CFT1946 Preclinical Data Accepted for a Poster Presentation at the AACR Annual Meeting 2024Phase 1 Dose Escalation Trials for CFT7455...
Biolase Launches State-of-the-Art All-Tissue Laser System To Accelerate Adoption of Lasers in Dentistry
Waterlase iPlus Premier Edition™ is being unveiled at the Chicago Midwinter Meeting 2024 LAKE FOREST, CA / ACCESSWIRE / February...
BigCommerce Announces Fourth Quarter and Fiscal Year 2023 Financial Results
AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading Open SaaS ecommerce platform...
Arqit and CableFree deliver world’s first quantum-safe 5G cellular technology products
LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, and...
Arqit and CableFree deliver world’s first quantum-safe 5G cellular technology products
LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, and...
Altair Expands Defense and Healthcare and Life Sciences Segment Leadership
Appointment of Caroline Phares and Chip Colbert to bolster Altair's industry expertise TROY, Mich., Feb. 22, 2024 /PRNewswire/ -- Altair (Nasdaq: ALTR),...
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
CAMBRIDGE, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular...
Cielo Announces Private Placement of Convertible Debenture Units for up to $5.0 Million to Advance Renewable Fuel Projects, Confirms Final Credit Facility Draw and Magazine Feature
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.CALGARY,...
Evergold – Magnetic Survey Over DEM1 Porphyry Prospect, B.C., Reveals New Mirror-Image DEM2 Target to the Southeast
TORONTO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Evergold Corp. (TSX-V: EVER, WKN: A2PTHZ) (“Evergold” or the “Company”) is pleased to...
First Mining Announces Final 2023 Exploration Drilling Results and Commencement of 2024 Drill Program at the Duparquet Gold Project
Highlights include new zone of mineralization extension returning 1.83 g/t Au over 7 m – extending mineralization 200 m along...
Mandalay Resources Provides 2023 Year-End Mineral Reserves and Resources Update for the Costerfield Mine, alongside an Interim Mineral Reserves Update for the Björkdal Mine
TORONTO, Feb. 22, 2024 /PRNewswire/ - Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX: MND) (OTCQB: MNDJF) released today updated...
WELL Provides Integration Update with Focus on Streamlining Business Operations for Improved Profitable Growth
VANCOUVER, BC, Feb. 22, 2024 /PRNewswire/ - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL" or the "Company"), a...
Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting
ZUG, Switzerland, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor...
Moderna Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Updates
Posts fourth quarter revenues of $2.8 billion, GAAP net income of $217 million and GAAP diluted EPS of $0.55 Reports...
Driven Brands Holdings Inc. Reports Fourth Quarter and Fiscal Year 2023 Results
--Fiscal 2023 revenue increased 13% powered by 7% same-store sales growth and 4% net store growth----Achieved 12 consecutive quarters of...
Canada Nickel Confirms Discovery at Mann Central, Successfully Completes Initial Drilling at Mann Northwest Property
Highlights TORONTO, Feb. 22, 2024 /PRNewswire/ - Canada Nickel Company Inc. ("Canada Nickel" or the "Company") (TSXV: CNC) (OTCQX: CNIKF) is...
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
New Drug Application (NDA) for KarXT for the treatment of schizophrenia in adults under review with a Prescription Drug User...
Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
– Significantly Strengthened Balance Sheet in January 2024 with Execution of Three-Tranche Private Placement of up to $240 Million, Extending...